Genetic analysis of a ganciclovir-resistant human cytomegalovirus mutant

被引:18
作者
Khan, RF
Mori, S
Eizuru, Y
Ishii, KK
Minamishima, Y [1 ]
机构
[1] Miyazaki Med Coll, Dept Microbiol, Miyazaki 8891692, Japan
[2] Kagoshima Univ, Fac Med, Ctr Chron Viral Dis, Div Persistent & Oncogen Viruses, Kagoshima 8908520, Japan
[3] Tohoku Univ, Sch Med, Dept Clin & Lab Med, Aoba Ku, Sendai, Miyagi 980, Japan
关键词
ganciclovir; cidofovir; phosphonoacetic acid; UL97; mutation;
D O I
10.1016/S0166-3542(98)00051-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We isolated a ganciclovir (GCV)-resistant human cytomegalovirus (HCMV) from a laboratory strain, AD169, and analysed the mutant. Attempts were also made to identify directly the mutated gene. The 50% inhibitory concentration (IC50) of GCV for the mutant strain was five times higher than that of the wild-type strain. The mutant strain showed similar sensitivity to phosphonoacetic acid and cidofovir as the wild-type strain. These data suggest mutation in the UL97 gene encoding for the phosphotransferase that phosphorylates GCV. Molecular analysis of the mutant strain revealed that a single base substitution of adenine by cytosine occurred at the 1796 nucleotide position of the UL97 gene region, resulting in the substitution of lysine by threonine at codon 599 in the UL97 gene product. Marker transfer experiment confirmed that this mutation conferred HCMV resistance to GCV. The mutation at codon 599 was easily identified by means of RsaI digestion of the selected PCR product. (C) 1998 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:95 / 103
页数:9
相关论文
共 35 条
[1]   VALUE OF A NEW RAPID NONRADIOACTIVE SEQUENCING METHOD FOR ANALYSIS OF THE CYTOMEGALOVIRUS UL97 GENE IN GANCICLOVIR-RESISTANT STRAINS [J].
ALAIN, S ;
MAZERON, MC ;
PEPIN, JM ;
BERGMANN, JF ;
NARWA, R ;
RASKINE, L ;
SANSONLEPORS, MJ .
JOURNAL OF VIROLOGICAL METHODS, 1995, 51 (2-3) :241-251
[2]   Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS [J].
Baldanti, F ;
Underwood, MR ;
Stanat, SC ;
Biron, KK ;
Chou, SW ;
Sarasini, A ;
Silini, E ;
Gerna, G .
JOURNAL OF VIROLOGY, 1996, 70 (03) :1390-1395
[3]   A 3-NUCLEOTIDE DELETION IN THE UL97 OPEN READING FRAME IS RESPONSIBLE FOR THE GANCICLOVIR RESISTANCE OF A HUMAN CYTOMEGALOVIRUS CLINICAL ISOLATE [J].
BALDANTI, F ;
SILINI, E ;
SARASINI, A ;
TALARICO, CL ;
STANAT, SC ;
BIRON, KK ;
FURIONE, M ;
BONO, F ;
PALU, G ;
GERNA, G .
JOURNAL OF VIROLOGY, 1995, 69 (02) :796-800
[4]  
Baldanti F, 1995, SCAND J INFECT DIS, P103
[5]   METABOLIC-ACTIVATION OF THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-L-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE IN HUMAN-DIPLOID FIBROBLASTS INFECTED WITH HUMAN CYTOMEGALO-VIRUS [J].
BIRON, KK ;
STANAT, SC ;
SORRELL, JB ;
FYFE, JA ;
KELLER, PM ;
LAMBE, CU ;
NELSON, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (08) :2473-2477
[6]   Value of a ligase chain reaction assay for detection of ganciclovir resistance-related mutation 594 in UL97 gene of human cytomegalovirus [J].
Bourgeois, C ;
Sixt, N ;
Bour, JB ;
Pothier, P .
JOURNAL OF VIROLOGICAL METHODS, 1997, 67 (02) :167-175
[7]   FREQUENCY OF UL97 PHOSPHOTRANSFERASE MUTATIONS RELATED TO GANCICLOVIR RESISTANCE IN CLINICAL CYTOMEGALOVIRUS ISOLATES [J].
CHOU, SW ;
GUENTZEL, S ;
MICHELS, KR ;
MINER, RC ;
DREW, WL .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01) :239-242
[8]   Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease [J].
Chou, SW ;
Marousek, G ;
Guentzel, S ;
Follansbee, SE ;
Poscher, ME ;
Lalezari, JP ;
Miner, RC ;
Drew, WL .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (03) :786-789
[9]   ANALYSIS OF THE UL97 PHOSPHOTRANSFERASE CODING SEQUENCE IN CLINICAL CYTOMEGALOVIRUS ISOLATES AND IDENTIFICATION OF MUTATIONS CONFERRING GANCICLOVIR RESISTANCE [J].
CHOU, SW ;
ERICE, A ;
JORDAN, MC ;
VERCELLOTTI, GM ;
MICHELS, KR ;
TALARICO, CL ;
STANAT, SC ;
BIRON, KK .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) :576-583
[10]  
Cihlar T, 1996, MOL PHARMACOL, V50, P1502